The Impact of Mindfulness Interventions on the Well-Being of Intensive Care, Emergency Department and Anaesthesia Staff: A Systematic Review
Abstract
Background: Critical care staff face unique stressors, including high patient acuity and intense work environments, leading to high rates of burnout and emotional fatigue. While mindfulness-based interventions (MBIs) are increasingly recognised for reducing stress among healthcare workers, no prior review has specifically examined their impact within critical care settings.
Aim: To evaluate the effectiveness of individual and workplace-delivered MBIs on improving well-being and reducing stress and burnout among critical care staff.
Study design: This systematic review was conducted starting with a literature search using MeSH terms across EBSCOhost platforms. Studies involving doctors, nurses and allied health professionals working in ICUs, EDs, CCUs and perioperative units were assessed. Clinical and non-clinical trials were included if they reported outcome data on burnout, stress, job satisfaction or overall well-being. Studies were assessed for bias using validated tools (RoB2, ROBINS-I, JMI, MMAT).
Results: The thirty studies included in this review indicate meditation-based interventions, particularly those combining in-person and app-guided formats, showed the most consistent benefits across measured data. Yoga and aromatherapy demonstrated improvements, though feasibility was often limited by space and schedule. Studies employing multiple modalities often resulted in the strongest outcomes. Qualitative findings supported improved emotional regulation and workplace…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.